SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2141392

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2141392

Egg Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global Egg Protein Hydrolysates Market was valued at USD 242 million in 2025 and is estimated to grow at a CAGR of 6.4% to reach USD 444.9 million by 2035.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$242 Million
Forecast Value$444.9 Million
CAGR6.4%

Market volume is projected to increase from 15,800 kilo tons in 2025 to 25,700 kilo tons by 2035. Egg protein hydrolysates are gaining commercial importance as the food and nutrition industries move beyond conventional egg processing toward higher-value functional ingredients. Their market potential depends not only on their protein content but also on the controlled hydrolysis process used to break proteins into shorter peptide chains. This processing approach can improve digestibility, solubility, and functionality for targeted formulations. Growing consumer interest in protein-rich nutrition, functional ingredients, sports nutrition, and specialized dietary products is supporting demand for egg-derived peptide ingredients. Manufacturers are also focusing on processing technologies that can deliver consistent peptide characteristics and application performance. The combination of established egg-processing infrastructure and increasing demand for premium nutritional ingredients is creating opportunities across food, supplement, and clinical nutrition applications. As ingredient developers continue to optimize hydrolysis processes and expand commercial formulations, egg protein hydrolysates are expected to gain broader use through 2035.

Egg white hydrolysates segment held USD 107.7 million in 2025 and is forecast to grow at a CAGR of 6.3% through 2035. Egg white proteins provide a diverse foundation for developing peptide-based ingredients with different functional characteristics. Their nutritional profile and processing versatility continue to support their use in specialized formulations. Research on egg white hydrolysates has highlighted their potential for rapid absorption, which maintains their relevance across sports nutrition and clinical nutrition applications. Continued development of peptide formulations and increasing demand for easily digestible protein ingredients are expected to support segment growth during the forecast period.

Nutraceutical applications segment recorded USD 67.8 million in 2025 and is expected to reach USD 119.8 million by 2035. Egg-derived peptide fractions are incorporated into nutraceutical formulations designed around digestive health, immune support, cardiovascular wellness, antioxidant properties, and anti-inflammatory benefits. Increasing consumer interest in functional nutrition and health-focused ingredients is creating additional opportunities for egg protein hydrolysates within the nutraceutical sector.

North America Egg Protein Hydrolysates Market captured USD 95.6 million in 2025. The United States generated USD 60.9 million in 2025 and benefits from well-established distribution and formulation channels serving sports nutrition, functional beverages, dietary supplements, and clinical nutrition. Integrated egg-processing supply chains also support reliable access to feedstock, while Canada adds regional processing capabilities and contributes to export-focused ingredient trade.

Major companies operating in the global Egg Protein Hydrolysates market include Taiyo Kagaku Co. Ltd., Merck KGaA, Kewpie Corporation, IGRECA, and Rembrandt Foods. Companies in the global Egg Protein Hydrolysates market are strengthening their market foothold through product development, processing technology improvements, capacity expansion, strategic partnerships, and broader distribution networks. Manufacturers are investing in hydrolysis technologies that can improve peptide consistency, solubility, digestibility, and functionality across different formulations. Expanding product portfolios allows companies to address demand from nutraceutical, sports nutrition, clinical nutrition, and functional food applications. Strategic collaborations with food manufacturers, supplement brands, ingredient distributors, and research organizations are helping businesses accelerate formulation development and increase market access. Companies are also optimizing egg-processing and peptide-production operations to improve yields, quality control, and cost efficiency. Geographic expansion is supporting access to new customers and emerging nutrition markets. In addition, businesses are emphasizing technical support, customized ingredient solutions, regulatory compliance, and reliable supply capabilities to build long-term B2B relationships and strengthen their competitive positions.

Product Code: 15263

Table of Contents

Chapter 1. Methodology

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2. Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Source Type
    • 2.2.3 Process
    • 2.2.4 Form
    • 2.2.5 Application
  • 2.3 TAM Analysis, 2025-2035
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3. Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter’s analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and Environmental Aspects
    • 3.12.1 Sustainable Practices
    • 3.12.2 Waste Reduction Strategies
    • 3.12.3 Energy Efficiency in Production
    • 3.12.4 Eco-friendly Initiatives
  • 3.13 Carbon Footprint Considerations

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5. Market Estimates and Forecast, By Source Type, 2025 - 2035 (USD Million, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Egg white hydrolysates
    • 5.2.1 High-purity protein formulations
    • 5.2.2 Allergen-reduced variants
  • 5.3 Egg yolk hydrolysates
    • 5.3.1 Phospholipid-rich peptides
    • 5.3.2 Lipoprotein-functional blends
  • 5.4 Whole egg hydrolysates
    • 5.4.1 Balanced amino acid profile
    • 5.4.2 General-purpose formulations

Chapter 6. Market Estimates and Forecast, By Process, 2025 - 2035 (USD Million, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Enzymatic hydrolysis
  • 6.3 Acid hydrolysis
  • 6.4 Other methods

Chapter 7. Market Estimates and Forecast, By Form, 2025 - 2035 (USD Million, Kilo Tons)

  • 7.1 Key trends
  • 7.2 Powder
  • 7.3 Liquid
  • 7.4 Capsules/Tablets

Chapter 8. Market Estimates and Forecast, By Application, 2025 - 2035 (USD Million, Kilo Tons)

  • 8.1 Key trends
  • 8.2 Nutraceuticals
    • 8.2.1 Digestive health
    • 8.2.2 Immune support
    • 8.2.3 Anti-inflammatory functionality
  • 8.3 Sports nutrition
    • 8.3.1 Pre-workout formulations
    • 8.3.2 Post-workout recovery formulations
    • 8.3.3 Muscle recovery peptides
  • 8.4 Infant & elderly nutrition
    • 8.4.1 Hypoallergenic protein blends
    • 8.4.2 Easily digestible amino profiles
  • 8.5 Clinical nutrition
    • 8.5.1 Tube-feeding solutions
    • 8.5.2 Recovery diets
  • 8.6 Functional food & beverages
    • 8.6.1 Bakery mixes
    • 8.6.2 Dairy and non-dairy beverages
  • 8.7 Cosmetics & personal care
    • 8.7.1 Anti-aging skincare
    • 8.7.2 Moisturizing applications
    • 8.7.3 Barrier-repair formulations

Chapter 9. Market Estimates and Forecast, By Region, 2025 - 2035 (USD Million, Kilo Tons)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East & Africa

Chapter 10. Company Profiles

  • 10.1 Kewpie Corporation
  • 10.2 Bouwhuis Enthoven BV
  • 10.3 Merck KGaA
  • 10.4 Rose Acre Farms
  • 10.5 Rembrandt Foods
  • 10.6 Sanovo Technology Group
  • 10.7 Ovostar Union
  • 10.8 Pulviver
  • 10.9 IGRECA
  • 10.10 Taiyo Kagaku Co., Ltd.
  • 10.11 Bioseutica
  • 10.12 Deb-El Food Products
  • 10.13 AgroAlta
  • 10.14 EW Group
  • 10.15 Ballas Egg
  • 10.16 Eurovo Srl
  • 10.17 Crystal Lake Farms
  • 10.18 Farm Pride Foods
  • 10.19 Dalian Hanovo Foods
  • 10.20 SOVIMO HELLAS S.A.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!